Unrealized potential of drug repositioning in Europe during COVID-19 and beyond: a physician’s perspective

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, July 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 163 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 9,819 followers.

RT @MichaelHenegha8: Learn about repurposing of drugs and haw to do it through the EMA. Good work from Chris Mulder @IHepatology @DebbieSha…

Reply Repost Favourite

Learn about repurposing of drugs and haw to do it through the EMA. Good work from Chris Mulder @IHepatology @DebbieShawcros1 @AASLDtweets @basl_events https://t.co/9K6y2K9ldI

Reply Repost Favourite

RT @editorjoppp: Unrealized potential of drug repositioning in #Europe during #COVID19 and beyond: a physcian’s perspective https://t.co/…

Reply Repost Favourite

RT @editorjoppp: Unrealized potential of drug repositioning in #Europe during #COVID19 and beyond: a physcian’s perspective https://t.co/…

Reply Repost Favourite

Unrealized potential of drug repositioning in #Europe during #COVID19 and beyond: a physcian’s perspective https://t.co/3SnKGWhqnx

Reply Repost Favourite